Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia.
Venugopal S, DiNardo CD, Loghavi S, Qiao W, Ravandi F, Konopleva M, Kadia T, Bhalla K, Jabbour E, Issa GC, Macaron W, Daver N, Borthakur G, Montalban-Bravo G, Yilmaz M, Patel KP, Kanagal-Shamanna R, Chien K, Maiti A, Kantarjian H, Short NJ.
Venugopal S, et al. Among authors: qiao w.
Am J Hematol. 2022 Dec;97(12):1560-1567. doi: 10.1002/ajh.26724. Epub 2022 Sep 26.
Am J Hematol. 2022.
PMID: 36087091
Free article.